The global market for Endoluminal Suturing Devices was estimated at US$71.4 Million in 2024 and is projected to reach US$106.8 Million by 2030, growing at a CAGR of 6.9% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Endoluminal Suturing Devices market.
The increasing prevalence of obesity and metabolic disorders has fueled the adoption of endoluminal bariatric procedures, such as endoscopic sleeve gastroplasty (ESG) and transoral gastric reduction techniques. Additionally, advancements in robotic-assisted suturing and AI-guided endoscopy have improved procedural outcomes, reducing the risk of complications such as post-operative leaks, perforations, and tissue trauma. As hospitals and surgical centers continue to invest in non-invasive therapeutic options, the market for endoluminal suturing devices is expected to expand significantly.
Additionally, AI-powered navigation systems and 3D imaging-assisted endoscopic suturing are increasing procedural success rates. The introduction of flexible and ergonomic suturing devices has further simplified transoral and transanal surgical interventions, making procedures more accessible for general surgeons and gastroenterologists. As the demand for scarless, incision-free surgical techniques continues to rise, manufacturers are focusing on developing ultra-precise, automated suturing tools for a variety of endoscopic applications.
The emergence of AI-driven surgical planning, biodegradable sutures, and next-generation suturing robotics is expected to further revolutionize the market. Additionally, increasing FDA and EU approvals for novel endoluminal devices, along with the expansion of outpatient and ambulatory surgical centers (ASCs), is making these procedures more accessible and cost-effective. As medical professionals and patients increasingly opt for scarless, minimally invasive alternatives, the endoluminal suturing device market is poised for continued growth.
Segments: Application (Bariatric Surgery, Gastrointestinal Surgery, Gastresophageal Reflux Surgery, Others); End-Use (Hospitals, Ambulatory Surgery Centers, Others)
Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.
Global Endoluminal Suturing Devices Market - Key Trends & Drivers Summarized
Why Are Endoluminal Suturing Devices Transforming Minimally Invasive Surgery?
Endoluminal suturing devices are revolutionizing minimally invasive surgery (MIS) by enabling precise, internal suturing without the need for external incisions. These devices are widely used in gastrointestinal (GI) procedures, bariatric surgeries, gastroesophageal reflux disease (GERD) treatments, and endoscopic tissue approximation. The growing preference for endoscopic and laparoscopic surgeries over traditional open surgery has significantly boosted demand for advanced suturing technologies that enhance procedural accuracy and patient recovery.The increasing prevalence of obesity and metabolic disorders has fueled the adoption of endoluminal bariatric procedures, such as endoscopic sleeve gastroplasty (ESG) and transoral gastric reduction techniques. Additionally, advancements in robotic-assisted suturing and AI-guided endoscopy have improved procedural outcomes, reducing the risk of complications such as post-operative leaks, perforations, and tissue trauma. As hospitals and surgical centers continue to invest in non-invasive therapeutic options, the market for endoluminal suturing devices is expected to expand significantly.
What Are the Latest Innovations in Endoluminal Suturing Devices?
The integration of robotics, AI, and real-time imaging has led to major breakthroughs in endoluminal suturing technology. Next-generation robotic suturing systems are enhancing precision and reducing human error, particularly in complex GI and bariatric surgeries. Innovations in self-tightening, biocompatible sutures have improved tissue healing and procedural durability, reducing the need for revision surgeries.Additionally, AI-powered navigation systems and 3D imaging-assisted endoscopic suturing are increasing procedural success rates. The introduction of flexible and ergonomic suturing devices has further simplified transoral and transanal surgical interventions, making procedures more accessible for general surgeons and gastroenterologists. As the demand for scarless, incision-free surgical techniques continues to rise, manufacturers are focusing on developing ultra-precise, automated suturing tools for a variety of endoscopic applications.
What Is Driving the Growth of the Endoluminal Suturing Devices Market?
The growth in the endoluminal suturing devices market is driven by rising obesity rates, increased demand for minimally invasive surgical procedures, and technological advancements in endoscopic instrumentation. The surge in bariatric procedures, particularly non-surgical weight loss interventions, has contributed significantly to market expansion. Additionally, rising healthcare expenditures, improved endoscopy training programs, and growing acceptance of robotic-assisted endoluminal procedures have boosted adoption rates.The emergence of AI-driven surgical planning, biodegradable sutures, and next-generation suturing robotics is expected to further revolutionize the market. Additionally, increasing FDA and EU approvals for novel endoluminal devices, along with the expansion of outpatient and ambulatory surgical centers (ASCs), is making these procedures more accessible and cost-effective. As medical professionals and patients increasingly opt for scarless, minimally invasive alternatives, the endoluminal suturing device market is poised for continued growth.
Report Scope
The report analyzes the Endoluminal Suturing Devices market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.Segments: Application (Bariatric Surgery, Gastrointestinal Surgery, Gastresophageal Reflux Surgery, Others); End-Use (Hospitals, Ambulatory Surgery Centers, Others)
Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Bariatric Surgery segment, which is expected to reach US$89.3 Million by 2030 with a CAGR of a 6.6%. The Gastrointestinal Surgery segment is also set to grow at 9.8% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $19.5 Million in 2024, and China, forecasted to grow at an impressive 10.8% CAGR to reach $22.2 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Endoluminal Suturing Devices Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Endoluminal Suturing Devices Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Endoluminal Suturing Devices Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as Apollo Endosurgery, Inc., B. Braun Melsungen AG, Boston Scientific Corporation, Cook Group Incorporated, Endo Tools Therapeutics S.A. and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 43 Featured):
- Apollo Endosurgery, Inc.
- B. Braun Melsungen AG
- Boston Scientific Corporation
- Cook Group Incorporated
- Endo Tools Therapeutics S.A.
- ErgoSuture
- Johnson & Johnson (Ethicon)
- Karl Storz SE & Co. KG
- LSI Solutions, Inc.
- Medtronic plc
- Mellon Medical B.V.
- Nitinotes Surgical
- Olympus Corporation
- Ovesco Endoscopy AG
- Richard Wolf GmbH
- Smith & Nephew plc
- Sutrue Ltd.
- Teleflex Incorporated
- Terumo Corporation
- USGI Medical
Tariff Impact Analysis: Key Insights for 2025
Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.
What’s Included in This Edition:
- Tariff-adjusted market forecasts by region and segment
- Analysis of cost and supply chain implications by sourcing and trade exposure
- Strategic insights into geographic shifts
Buyers receive a free July 2025 update with:
- Finalized tariff impacts and new trade agreement effects
- Updated projections reflecting global sourcing and cost shifts
- Expanded country-specific coverage across the industry
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Apollo Endosurgery, Inc.
- B. Braun Melsungen AG
- Boston Scientific Corporation
- Cook Group Incorporated
- Endo Tools Therapeutics S.A.
- ErgoSuture
- Johnson & Johnson (Ethicon)
- Karl Storz SE & Co. KG
- LSI Solutions, Inc.
- Medtronic plc
- Mellon Medical B.V.
- Nitinotes Surgical
- Olympus Corporation
- Ovesco Endoscopy AG
- Richard Wolf GmbH
- Smith & Nephew plc
- Sutrue Ltd.
- Teleflex Incorporated
- Terumo Corporation
- USGI Medical
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 82 |
| Published | April 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 71.4 Million |
| Forecasted Market Value ( USD | $ 106.8 Million |
| Compound Annual Growth Rate | 6.9% |
| Regions Covered | Global |
